GAM Holding’s Alexion Pharmaceuticals ALXN Stock Holding History

GAM Holding’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2	Closed	–	–	372
2021 Q2	$0	Sell	2 -25,401	-100%	-$4.36M	﹤0.01%	365
2021 Q1	$3.88M	Buy	+25,403	New	+$3.93M	0.18%	150
2020 Q4	–	Sell	-32,642	Closed	-$3.73M	–	356
2020 Q3	$3.73M	Buy	32,642 +235	+0.7%	+$25.4K	0.23%	138
2020 Q2	$3.64M	Buy	32,407 +6	+0%	+$637	0.23%	136
2020 Q1	$2.91M	Buy	32,401 +92	+0.3%	+$9.03K	0.2%	140
2019 Q4	$3.49M	Buy	32,309 +9	+0%	+$963	0.17%	163
2019 Q3	$3.16M	Hold	32,300	–	–	0.14%	173
2019 Q2	$4.23M	Sell	32,300 -8,860	-22%	-$1.14M	0.17%	139
2019 Q1	$5.56M	Buy	41,160 +8,858	+27%	+$1.1M	0.23%	111
2018 Q4	$3.15M	Sell	32,302 -3,900	-11%	-$461K	0.16%	150
2018 Q3	$5.03M	Buy	36,202 +2	+0%	+$251	0.18%	143
2018 Q2	$4.49M	Hold	36,200	–	–	0.16%	160
2018 Q1	$4.04M	Hold	36,200	–	–	0.14%	183
2017 Q4	$4.33M	Hold	36,200	–	–	0.13%	190
2017 Q3	$5.08M	Sell	36,200 -5,745	-14%	-$781K	0.21%	143
2017 Q2	$5.1M	Sell	41,945 -26,000	-38%	-$3.03M	0.08%	321
2017 Q1	$8.24M	Sell	67,945 -16,263	-19%	-$2.1M	0.13%	191
2016 Q4	$10.3M	Buy	84,208 +21,038	+33%	+$2.57M	0.18%	143
2016 Q3	$7.74M	Buy	63,170 +38,846	+160%	+$5M	0.14%	177
2016 Q2	$2.84M	Sell	24,324 -45,590	-65%	-$6.47M	0.04%	431
2016 Q1	$9.73M	Buy	69,914 +11,400	+19%	+$1.67M	0.16%	153
2015 Q4	$11.2M	Buy	58,514 +5,681	+11%	+$992K	0.17%	147
2015 Q3	$8.26M	Sell	52,833 -7,900	-13%	-$1.44M	0.14%	174
2015 Q2	$11M	Buy	60,733 +16,946	+39%	+$2.92M	0.16%	159
2015 Q1	$7.59M	Sell	43,787 -9,300	-18%	-$1.68M	0.11%	207
2014 Q4	$9.82M	Buy	53,087 +7,854	+17%	+$1.46M	0.15%	179
2014 Q3	$7.5M	Buy	45,233 +12,000	+36%	+$1.97M	0.11%	218
2014 Q2	$5.19M	Buy	33,233 +20	+0.1%	+$3.16K	0.08%	267
2014 Q1	$5.05M	Sell	33,213 -20,056	-38%	-$3.19M	0.08%	280
2013 Q4	$7.09M	Hold	53,269	–	–	0.12%	193
2013 Q3	$6.19M	Sell	53,269 -16,981	-24%	-$1.86M	0.12%	212
2013 Q2	$6.48M	Buy	+70,250	New	+$6.77M	0.14%	195

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return